Literature DB >> 33138749

Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications

Devina Lobine1, Marie Carene Nancy Picot-Allain1, Nabeelah Sadeer1, Sharmeen Jugreet1, Mohamad Fawzi Mahomoodally2,3, Gokhan Zengin4.   

Abstract

BACKGROUND: Diabetes Mellitus (DM) is a severe endocrine metabolic disease coupled with various long-term complications. A plethora of targets have been identified, however with possible adverse effects. Therefore, researchers are in the perpetual quest for safe and more effective therapeutics. Natural products, particularly derived from plants have proven to exert anti-diabetic effects via diverse mechanisms.
METHODS: An overview of DM pathogenesis and its associated micro- and macro-vascular complications is presented. Possible underlying mechanisms of herbal remedies in DM management are provided highlighting some key therapeutic targets. The review also appraises the recent progress of herbal products in treating DM through regulating inflammation and gut microbiota. Finally, currently available pharmacological treatments are discussed.
RESULTS: The results show that numerous plants have proved to be promising sources of insulin secreting agents, αglucosidase and α-amylase inhibitors. Among the non- conventional targets, inhibition of key enzymes such as lipase, cholinesterases and angiotensin converting enzyme have been directly and/or indirectly linked to DM and DM complications. For instance, hypericin, pseudohypericin and I3,II8-biapigenin isolated from Hypericum perforatum L., and palmatine and columbamine isolated from Dichocarpum auriculatum (Franch.) W. T. Wang & P. K have been found to be powerful lipase and cholinesterase inhibitors, respectively. Moreover, a number of plant-derived compounds such as feruloylated oligosaccharides from maize bran, baicalein and berberine are reported to mediate anti-diabetic property via modulation of gut microbiota.
CONCLUSION: The information amassed in this review is anticipated to provide useful scientific baseline information to support advanced research in natural antidiabetic drug development. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Diabetes; angiotensin converting enzyme; cholinesterase; drug; lipase; microbiome

Year:  2020        PMID: 33138749     DOI: 10.2174/0929867327666201102120120

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  3 in total

Review 1.  Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus.

Authors:  Fahadul Islam; Jannatul Fardous Khadija; Md Rezaul Islam; Sheikh Shohag; Saikat Mitra; Saad Alghamdi; Ahmad O Babalghith; Abdulrahman Theyab; Mohammad Tauhidur Rahman; Aklima Akter; Abdullah Al Mamun; Fahad A Alhumaydhi; Talha Bin Emran
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-21       Impact factor: 2.650

2.  Elucidating the Neuroprotective Effect of Tecoma stans Leaf Extract in STZ-Induced Diabetic Neuropathy.

Authors:  Amit Gupta; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Shivam Yadav; Khalid Anwer; Celia Vargas-De-La Cruz; Sridevi Chigurupati; Abdullah Farasani; Saurabh Bhatia
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-26       Impact factor: 2.650

3.  Pentacyclic Triterpenoids from Sabia discolor Dunn and Their α-Glycosidase Inhibitory Activities.

Authors:  Jin-Hong Ma; Dan Hu; Lu-Lu Deng; Jiang Li; Xiao-Jiang Hao; Shu-Zhen Mu
Journal:  Molecules       Date:  2022-03-27       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.